The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Open accessAbstract
Macrolides are composed of 14 (erythromycin and clarithromycin)-, 15 (azithromycin)-, or 16 (josamycin, spiramycin, and tylosin)-membered lactones to which are attached amino and/or neutral sugars via glycosidic bonds. Erythromycin was introduced in 1952 as the first macrolide antibiotic. Unfortunately, within a year, erythromycin-resistant (Emr) staphylococci from the United States, Europe, and Japan were described (101). Erythromycin is produced by Saccharopolyspora erythraea, while the newer macrolides are semisynthetic molecules with substitutions on the lactone. The newer derivatives, such as clarithromycin and azithromycin, have improved intracellular and tissue penetration, are more stable, are better absorbed, have a lower incidence of gastrointestinal side effects, and are less likely to interact with other drugs. They are useable against a wider range of infectious bacteria, such as Legionella, Chlamydia, Haemophilus, and some Mycobacterium species (not M. tuberculosis), and their pharmacokinetics provide for less frequent dosing than erythromycin (21, 47, 96, 97). As a result, the usage of the newer macrolides has increased dramatically over the last few years, which has led to increased exposure of bacterial populations to macrolides (101–103, 107). Macrolides inhibit protein synthesis by stimulating dissociation of the peptidyl-tRNA molecule from the ribosomes during elongation (101, 103). This results in chain termination and a reversible stoppage of protein synthesis. The first mechanism of macrolide resistance described was due to posttranscriptional modification of the 23S rRNA by the adenine-N6 methyltransferase (101–103). These enzymes add one or two methyl groups to a single adenine (A2058 in Escherichia coli) in the 23S rRNA moiety. Over the last 30 years, a number of adenine-N6-methyltransferases from different species, genera, and isolates have been described. In general, genes encoding these methylases have been designated erm (erythromycin ribosome methylation), although there are exceptions, especially in the antibiotic-producing organisms (see Tables Tables11 and and3)3) (103). As the number of erm genes described has grown, the nomenclature for these genes has varied and has been inconsistent (Table (Table1).1). In some cases, unrelated genes have been given the same letter designation, while in other cases, highly related genes (>90% identity) have been given different names. TABLE 1 rRNA methylase genes involved in MLSB resistance TABLE 3 Location of antibiotic resistance genesa The binding site in the 50S ribosomal subunit for erythromycin overlaps the binding site of the newer macrolides, as well as the structurally unrelated lincosamides and streptogramin B antibiotics. The modification by methylase(s) reduces the binding of all three classes of antibiotics, which results in resistance against macrolides, lincosamides, and streptogramin B antibiotics (MLSB). The rRNA methylases are the best studied among macrolide resistance mechanisms (47, 101–103). However, a variety of other mechanisms have been described which also confer resistance (Table (Table2).2). Many of these alternative mechanisms of resistance confer resistance to only one or two of the antibiotic classes of the MLSB complex. TABLE 2 Efflux and inactivating genes In this review, we suggest a new nomenclature for naming MLS genes and propose to use the rules developed for identifying and naming new tetracycline resistance genes (51, 52). This system, with a few recent modifications, was originally designed because of the ability of two genes to be distinguished uniquely by DNA-DNA probe methodology (51). It was generally found that two genes with <80% amino acid sequence identity provided enough variability in nucleotide sequence to permit distinct probes to be designed. Although many investigators are likely to sequence new genes, the use of probe technology allows rapid identification of isolates containing potentially new genes, as well as a reliable way to screen populations and determine the frequency of any one resistant determinant. Therefore, we continued this paradigm by assigning two genes of ≥80% amino acid identity to the same class and same letter designation, while two genes that show ≤79% amino acid identity are given a different letter designation. Table Table11 shows the results of the classification, with some classes having members with little variability, while others, like classes A and O, show a greater range of homology at both the DNA and amino acid levels. As new gene sequences emerge, ideally they will need to be compared by oligonucleotide probe hybridization and/or sequence analysis against the bank of known genes before a new designation is assigned. If multiple genes are available in any one class, especially when there is a range as in class A, then all representative members of the class should be examined, not just one.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2019) · ASM Press eBooks · doi:10.1128/9781683670131 · Cited by 1,009
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Detection of erythromycin-resistant determinants by PCR
Sutcliffe, J., Grebe, T., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2562 · Cited by 989
Self-citationBacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
Self-citationKatz, E., Thompson, C. J., & Hopwood, D. A. (1983) · Microbiology · doi:10.1099/00221287-129-9-2703 · Cited by 628
Sutcliffe, J., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1817 · Cited by 619
Self-citationConjugative transposons: an unusual and diverse set of integrated gene transfer elements
Salyers, A. A., Shoemaker, N. B., Stevens, A. M., & Li, L. Y. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.4.579-590.1995 · Cited by 423
Unconstrained bacterial promiscuity: the Tn916–Tn1545 family of conjugative transposons
Clewell, D. B., Flannagan, S. E., Jaworski, D. D., & Clewell, D. B. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88930-1 · Cited by 391
Clancy, J., Petitpas, J., Dib‐Hajj, F., Yuan, W., Cronan, M., Kamath, A. V., Bergeron, J., & Retsema, J. A. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.01521.x · Cited by 358
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae
Tait-Kamradt, A., Clancy, J., Cronan, M., Dib-Hajj, F., Wondrack, L., Yuan, W., & Sutcliffe, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2251 · Cited by 298
Self-citationInsights into erythromycin action from studies of its activity as inducer of resistance
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.797 · Cited by 267
A Novel Erythromycin Resistance Methylase Gene ( ermTR ) in Streptococcus pyogenes
Seppälä, H., Skurnik, M., Soini, H., Roberts, M. C., & Huovinen, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.257 · Cited by 258
Self-citationPresence of erm gene classes in Gram-positive bacteria of animal and human origin in Denmark
Jensen, L. (1999) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00539-4 · Cited by 235
Self-citationLeclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1273 · Cited by 230
Self-citationPeschke, U., Schmidt, H., Zhang, H., & Piepersberg, W. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02338.x · Cited by 216
Nomenclature for New Tetracycline Resistance Determinants
Levy, S. B., McMurry, L. M., Barbosa, T. M., Burdett, V., Courvalin, P., Hillen, W., Roberts, M. C., Rood, J. I., & Taylor, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1523 · Cited by 211
Self-citationMeier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J., & Böttger, E. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.381 · Cited by 195
Bozdogan, B., Berrezouga, L., Kuo, M.-S., Yurek, D. A., Farley, K. A., Stockman, B. J., & Leclercq, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.925 · Cited by 180
A variety of Gram-positive bacteria carry mobile mef genes
Luna, V. A., Coates, P., Eady, E. A., Cove, J. H., Nguyen, T. T. H., & Roberts, M. C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.19 · Cited by 168
Self-citationAllignet, J., Loncle, V., & Solh, N. E. (1992) · Gene · doi:10.1016/0378-1119(92)90488-b · Cited by 158
Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545
Trieu‐Cuot, P., Poyart, C., Carlier, C., & Courvalin, P. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3660 · Cited by 151
Self-citationErythromycin Resistance Genes in Group A Streptococci in Finland
Kataja, J., Huovinen, P., Skurnik, M., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.48 · Cited by 150
Monod, M., Denoya, C. D., & Dubnau, D. A. (1986) · Journal of Bacteriology · doi:10.1128/jb.167.1.138-147.1986 · Cited by 149
Arthur, M., Brisson-Noël, A., & Courvalin, P. M. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.6.783 · Cited by 135
Self-citationEvidence for natural gene transfer from gram-positive cocci to Escherichia coli
Brisson-Noël, A., Arthur, M., & Courvalin, P. M. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.4.1739-1745.1988 · Cited by 132
Self-citationRende-Fournier, R., Leclercq, R., Galimand, M., Duval, J., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2119 · Cited by 127
Self-citationHost range of the ermF rRNA methylase gene in bacteria of human and animal origin
Chung, W. O., Werckenthin, C., Schwarz, Š., & Roberts, M. C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.5 · Cited by 124
Self-citationArthur, M., Andremont, A., & Courvalin, P. M. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.3.404 · Cited by 118
Self-citationRoss, J. I., Eady, E. A., Cove, J. H., JONES, C. E., Ratyal, A. H., Miller, Y., Vyakrnam, S., & Cunliffe, W. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1162 · Cited by 116
Rasmussen, J. L., Odelson, D. A., & Macrina, F. L. (1986) · Journal of Bacteriology · doi:10.1128/jb.168.2.523-533.1986 · Cited by 116
Allignet, J., & Solh, N. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2027 · Cited by 115
O'Hara, K., Kanda, T., Ohmiya, K., Ebisu, T., & Kono, M. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1354 · Cited by 114
Allignet, J., Loncle, V., Simenel, C., Delepierre, M., & Solh, N. E. (1993) · Gene · doi:10.1016/0378-1119(93)90350-c · Cited by 110
Tetracycline resistance determinants in Mycobacterium and Streptomyces species
Pang, Y., Brown, B. A., STEINGRUBE, V. A., Wallace, R. J., & Roberts, M. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1408 · Cited by 109
Self-citationNoguchi, N., EMURA, A., Matsuyama, H., O'Hara, K., Sasatsu, M., & Kono, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2359 · Cited by 105
Roberts, M. C., Chung, W. O., Roe, D. E., Xia, M., Márquez, C., Borthagaray, G., Whittington, W. L. H., & Holmes, K. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1367 · Cited by 105
Self-citationNomenclature for tetracycline resistance determinants
Levy, S. B., McMurry, L. M., Burdett, V., Courvalin, P. M., Hillen, W., Roberts, M. C., & Taylor, D. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1373 · Cited by 100
Self-citationBrisson-Noël, A., Delrieu, P., Samain, D., & Courvalin, P. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37532-x · Cited by 98
Self-citationHammerum, A. M., Jensen, L. B. ̄. ⁄., & Aarestrup, F. M. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13267.x · Cited by 98
Self-citationSequence similarity between macrolide-resistance determinants and ATP-binding transport proteins
Schoner, B. E., Geistlich, M., Rosteck, P. R., et al. (1992) · Gene · doi:10.1016/0378-1119(92)90545-z · Cited by 96
Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli
Ounissi, H., & Courvalin, P. M. (1985) · Gene · doi:10.1016/0378-1119(85)90005-8 · Cited by 96
Self-citationRosteck, P. R., Reynolds, P. A., & Hershberger, C. L. (1991) · Gene · doi:10.1016/0378-1119(91)90533-h · Cited by 94
Allignet, J., Loncle, V., Mazodier, P., & Solh, N. E. (1988) · Plasmid · doi:10.1016/0147-619x(88)90034-0 · Cited by 91
Richardson, M. A., Kuhstoss, S., Solenberg, P. J., et al. (1987) · Gene · doi:10.1016/0378-1119(87)90187-9 · Cited by 90
Weisblum, B. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80212-4 · Cited by 87
Zalacaín, M., & Cundliffe, E. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.8.4254-4260.1989 · Cited by 84
Hächler, H., Kayser, F. H., & Berger‐Bächi, B. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1033 · Cited by 82
Allignet, J., Liassine, N., & Solh, N. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1794 · Cited by 79
A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus
Matsuoka, M., Endou, K., Kobayashi, H., Inoue, M., & Nakajima, Y. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13232.x · Cited by 75
Werner, G., & Witte, W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1813 · Cited by 73
Jensen, L. B., Hammerum, A. M., Aarestrup, F. M., van den Bogaard, A. E. J. M., & Stobberingh, E. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3330 · Cited by 71
Self-citationAzithromycin and erythromycin resistant Neisseria gonorrhoea e following treatment with azithromycin
Young, H.-K., Moyes, A., & McMillan, A. (1997) · International Journal of STD & AIDS · doi:10.1258/0956462971920127 · Cited by 69
Cloning and nucleotide sequence of a carbomycin-resistance gene from Streptomyces thermotolerans
Epp, J. K., Burgett, S. G., & Schoner, B. E. (1987) · Gene · doi:10.1016/0378-1119(87)90094-1 · Cited by 67
Cloning of tlrD, a fourth resistance gene, from the tyiosin producer, Streptomyces fradiae
Zalacaín, M., & Cundliffe, E. (1991) · Gene · doi:10.1016/0378-1119(91)90021-3 · Cited by 63
Monod, M., Mohan, S., & Dubnau, D. A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.1.340-350.1987 · Cited by 62
Smith, C. J. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.10.4589-4596.1987 · Cited by 60
Nucleotide sequence of gene linA encoding resistance to lincosamides in Staphylococcus haemolyticus
Brisson-Noël, A., & Courvalin, P. M. (1986) · Gene · doi:10.1016/0378-1119(86)90213-1 · Cited by 60
Self-citationStructural Alterations in the Translational Attenuator of Constitutively Expressed ermC Genes
Werckenthin, C., Schwarz, Š., & Westh, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1681 · Cited by 59
Zhang, H., Schmidt, H., & Piepersberg, W. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01388.x · Cited by 59
Berryman, D., Lyristis, M., & Rood, J. I. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1041 · Cited by 51
Self-citationCharacterization of tetracycline and erythromycin resistance determinants in Treponema denticola
Roberts, M. C., Chung, W. O., & Roe, D. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1690 · Cited by 48
Self-citationBerryman, D., & Rood, J. I. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1346 · Cited by 46
Self-citationNoguchi, N., Katayama, J., & Ohara, K. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08530.x · Cited by 45
The streptogramin antibiotics: update on their mechanism of action
Beyer, D., & Pepper, K. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.4.591 · Cited by 42
An erythromycin-resistance gene from an erythromycin-producing strain of Arthrobacter sp
Roberts, A. N., Hudson, G. S., & Brenner, S. (1985) · Gene · doi:10.1016/0378-1119(85)90004-6 · Cited by 41
Characterization of the genetic basis of antibiotic resistance in Clostridium difficle
Roberts, M. C., McFarland, L. V., Mullany, P. P., & Mulligan, M. E. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.3.419 · Cited by 40
Self-citationMilton, I. D. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90377-z · Cited by 39
Emergence of the M Phenotype of Erythromycin-Resistant Pneumococci in South Africa
Widdowson, C. A., & Klugman, K. P. (1998) · Emerging infectious diseases · doi:10.3201/eid0402.980216 · Cited by 38
Plasmid mediated pristinamycin resistance: PH 1A, a pristinamycin 1A hydrolase.
Goffic, F. L., Capmau, M.-L., Abbe, J., Cerceau, C., Dublanchet, A., & Duval, J. (1977) · PubMed · Cited by 36
Calcutt, M. J., & Cundliffe, E. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.8.4710-4714.1990 · Cited by 34
Kovalic, D., Giannattasio, R. B., Jin, H. J., & Weisblum, B. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.22.6992-6998.1994 · Cited by 33
Oh, T., Kwon, A., & Choi, E. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.21.5788-5791.1998 · Cited by 28
Halula, M. C., Manning, S., & Macrina, F. L. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.12.3453 · Cited by 27
Masaharu, I., Toshiro, M., Horinouchi, S., et al. (1994) · Gene · doi:10.1016/0378-1119(94)90125-2 · Cited by 24
Nucleotide sequence of the erythromycin resistance gene from theCorynebacteriumplasmid pNG2
Hodgson, A. L. M., Krywult, J., & Radford, A. J. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.7.1891 · Cited by 22
Role of mRNA termination in regulation of ermK
Choi, S., Kim, S., Oh, T. G., & Choi, E. C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.6.2065-2067.1997 · Cited by 20
Hara, O., & Hutchinson, C. R. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.977 · Cited by 20
Aparicio, G., Buche, A., Méndez, C., & Salas, J. A. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08378.x · Cited by 12
Cited by
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Antibiotic resistance genes in water environment
Zhang, X.-X., Zhang, T., & Fang, H. H. P. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1829-z · Cited by 998
The use of bacterial spore formers as probiotics: Table 1
Hong, H. A., Duc, L. H., & Cutting, S. M. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.001 · Cited by 975
Metadata
- Authors
- Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1999-12
- Volume
- 43
- Issue
- 12
- Pages
- 2823-2830
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2171076011
- Cited by
- 874
- References
- 78
- FWCI
- 20.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.